KU Center for Food Safety, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea.
KU Center for Food Safety, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea.
Poult Sci. 2020 Nov;99(11):5999-6006. doi: 10.1016/j.psj.2020.07.032. Epub 2020 Aug 7.
In this study, we aimed to assess the feasibility of the lactic acid bacterium Lactobacillus kefiranofaciens DN1 (LKF_DN1) and the yeast Kluyveromyces marxianus KU140723-05 (KMA5), recently isolated from kefir, as probiotics. Specifically, we evaluated the effect of early administration of these 2 microbes on the inhibition of Salmonella Enteritidis (SE) colonization in neonatal chicks. We also examined the effects of exposure of chicks to probiotics before SE exposure on the reduction in the number of gut SE. A total of 108 1-day-old specific-pathogen-free male layer chicks were used for 3 independent experiments. The experimental chicks were randomly divided into 6 groups (negative control: basal diet [BD] without probiotics and SE; positive control: BD; probiotic group [PG] 1: BD + LKF_DN1; PG2: BD + KMA5; PG3: BD + LKF_DN1 + KMA5; and PG4: BD+ a commercial product IDF-7), all of which, except negative control, were coadministered with SE strain resistant to rifampicin (SERR). We found that the administration of LKF_DN1 and/or KMA5 reduced the number of viable cells of the SERR strain in chicks by up to 1.90 log, relative to positive control chicks. Compared with late administration (day [D] 10 and D11), early administration (D1 and D2) of the probiotics was more effective in reducing SERR cell numbers in the gut. Furthermore, we detected no significant difference in the reduction of gut SERR cell numbers in chicks from the same groups exposed to the probiotics at D10 and D11 before and after administration with SERR. Collectively, our findings indicate that, as dietary additives, LKF_DN1 and KMA5 showed potential probiotic activity in chicks. Moreover, the combination of the lactic acid bacteria and/or yeast strain was found to rapidly reduce SE numbers in the chick gut and showed a prolonged inhibitory effect against SE colonization. We, thus, propose that the administration of these 2 probiotics, as early as possible after hatching, would be considerably effective in controlling SE colonization in the guts of chicks.
在这项研究中,我们旨在评估从开菲尔中分离出来的乳酸菌 Lactobacillus kefiranofaciens DN1(LKF_DN1)和酵母 Kluyveromyces marxianus KU140723-05(KMA5)作为益生菌的可行性。具体来说,我们评估了早期给予这两种微生物对抑制新生小鸡中肠炎沙门氏菌(SE)定植的影响。我们还研究了在 SE 暴露前暴露于益生菌对减少肠道 SE 数量的影响。总共使用了 108 只 1 日龄的无特定病原体雄性层小鸡进行了 3 项独立实验。实验小鸡被随机分为 6 组(阴性对照:不含益生菌和 SE 的基础饮食 [BD];阳性对照:BD;益生菌组 [PG]1:BD+LKF_DN1;PG2:BD+KMA5;PG3:BD+LKF_DN1+KMA5;PG4:BD+商业产品 IDF-7),除阴性对照组外,所有组均给予对利福平(RIF)耐药的 SE 菌株。我们发现,与阳性对照组相比,给予 LKF_DN1 和/或 KMA5 可使小鸡中 SERR 菌株的活菌数减少多达 1.90 对数。与晚期给药(第 10 天和第 11 天)相比,早期(第 1 天和第 2 天)给予益生菌更有效地减少肠道中的 SERR 细胞数量。此外,我们发现,在给予 SERR 之前和之后,在同一组的小鸡中,在第 10 天和第 11 天暴露于益生菌时,肠道中 SERR 细胞数量的减少没有显著差异。总之,我们的研究结果表明,作为膳食添加剂,LKF_DN1 和 KMA5 在小鸡中具有潜在的益生菌活性。此外,发现乳酸菌和/或酵母菌株的组合可迅速减少鸡肠道中的 SE 数量,并对 SE 定植表现出持久的抑制作用。因此,我们建议在孵化后尽早给予这两种益生菌,这将在控制小鸡肠道中的 SE 定植方面非常有效。